Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging

This article summarises the expert presentations and the delegate voting on consensus statements discussed at the Forum.Results and conclusionsIt was concluded that gadoxetic acid –enhanced MRI has higher sensitivity for the diagnosis of hepatocellular carcinoma (HCC), when compared with multidetector CT, by utilising features of hyperenhancement in the arterial phase and hypointensity in the hepatobiliary phase (HBP). Recent HCC management guidelines recognise an increasin g role for gadoxetic acid–enhanced MRI in early diagnosis and monitoring post-resection. Additional research is needed to define the role of HBP in predicting microvascular invasion, to better define washout during the transitional phase in gadoxetic acid–enhanced MRI for HCC diagnosis, and to r educe the artefacts encountered in the arterial phase. Technical developments are being directed to shortening the MRI protocol for reducing time and patient discomfort and toward utilising faster imaging and non-Cartesian free-breathing approaches that have the potential to improve multiphasic dyna mic imaging.Key Points•Gadoxetic acid –enhanced MRI provides higher diagnostic sensitivity than CT for diagnosing HCC.•Gadoxetic acid –enhanced MRI has roles in early-HCC diagnosis and monitoring post-resection response.•Faster imaging and free-breathing approaches have potential to improve multiphasic dynamic imaging.
Source: European Radiology - Category: Radiology Source Type: research